Jetema Co Rendement FCF

Que fait Jetema Co ? Jetema Co Ltd is a South Korean company based in Wonju, Gangwon-Do, operating within the Health Care sector, specifically in the Pharmaceuticals industry. The company focuses on the manufacturing and distribution of aesthetic medical products, including dermal fillers, threads, botulinum toxin, and other medical devices. Jetema Co Ltd went public on November 14, 2019, with its stock listed under the ticker 216080.KQ and ISIN KR7216080002. The company currently employs 187 full-time staff members. Jetema's product portfolio includes hyaluronic acid fillers designed for facial beauty treatments, as well as medical devices aimed at improving wrinkles, facial contours, and volume. Additionally, the company produces laser equipment for treating conditions such as leukoplakia, psoriasis, and alopecia areata, along with lifting medical devices, cosmetic mask packs, and pharmaceutical excipients. The company's website is www.jetema.com. Jetema Co Ltd is engaged in the development, manufacturing, and distribution of its products, with a focus on aesthetic and medical applications. The company does not disclose further details on its financial performance, acquisitions, or specific product names beyond what is publicly available. It operates primarily in South Korea, serving both domestic and international markets through its product offerings. Jetema Co est l'une des entreprises les plus populaires sur Eulerpool.